chartexchange

Cumberland Pharmaceuticals Inc (CPIX) (Q3 2026) Earnings Call Highlights: $100 Million Apotex ...

GuruFocus | Nov 12, 2026 6:04 PM EST

Cumberland Pharmaceuticals Inc (CPIX) closed a transformational $100 million transaction, ended the quarter with $80.6 million in cash and no debt, and is advancing ifetroban toward an NDA… Related Stocks: CPIX ,

Read original article